Journal article

Circulating 25-Hydroxyvitamin D-3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort

David C Muller, Anouar Fanidi, Oivind Midttun, Annika Steffen, Laure Dossus, Marie-Christine Boutron-Ruault, Gianluca Severi, Tilman Kuehn, Verena Katzke, Ramon Alonso de la Torreon, Carlos A Gonzalez, Maria-Jose Sanchez, Miren Dorronsoro, Carmen Santiuste, Aurelio Barricarte, Kay-Tee Khaw, Nick Wareham, Ruth C Travis, Antonia Trichopoulou, Maria Giotaki Show all

American Journal of Epidemiology | OXFORD UNIV PRESS INC | Published : 2014

Grants

Awarded by Spanish Ministry of Health


Awarded by Cancer Research UK


Awarded by Medical Research Council


Awarded by National Institute for Health Research


Funding Acknowledgements

The World Cancer Research Fund supported the biochemical analyses. The work by D.C.M. that was reported in this paper was conducted during the tenure of an IARC-Australia postdoctoral fellowship from the International Agency for Research on Cancer, supported by the Cancer Council Australia.The European Prospective Investigation into Cancer and Nutrition has been supported by the Europe Against Cancer Program of the European Commission; Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; the Danish Cancer Society; the Health Research Fund of the Spanish Ministry of Health; the Spanish regional governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; the Catalan Institute of Oncology; the Spanish Ministry of Health (grant RETICC DR06/0020); Cancer Research United Kingdom; the Medical Research Council, United Kingdom; the Greek Ministry of Health; the Stavros Niarchos Foundation; the Hellenic Health Foundation; the Italian Association for Research on Cancer; the Italian National Research Council, Fondazione-Istituto Banco Napoli; the Associazione Italiana per la Ricerca sul Cancro, Milan, Italy; the Compagnia di San Paolo; the Dutch Ministry of Public Health, Welfare, and Sports; the World Cancer Research Fund; the Swedish Cancer Society; the Swedish Scientific Council; the Regional Government of Vasterbotten, Sweden; NordForsk, Norway; the French League against Cancer; the National Institute for Health and Medical Research, France; Mutuelle Generale de l'Education Nationale, France; 3M Co., France; the Gustave Roussy Institute; and the General Councils of France.